RecruitingNot ApplicableNCT06488274

Evolution of Functional Gastrointestinal Disorders in Infants Fed With a New Infant Formula

Assessment of the Evolution of functIonal Gastrointestinal Disorders in Infants During Their Dietary Management With a New Infant Formula


Sponsor

United Pharmaceuticals

Enrollment

139 participants

Start Date

Oct 21, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

This study aims to assess the evolution of functional gastrointestinal disorders (FGIDs) in infants fed with a new infant formula, using the Gastrointestinal (GI) and gastroesophageal reflux (GER) (GIGER) scale through an interventional, open-label, non-comparative multicenter study.


Eligibility

Max Age: 4 Months

Plain Language Summary

Simplified for easier understanding

This study assesses whether a new infant formula reduces common digestive problems in babies — such as spitting up, colic, and constipation — over a 30-day period (with an optional 90-day extension). These functional gastrointestinal disorders are very common in the first months of life and can cause significant distress for infants and families. Eligible participants are formula-fed infants up to 4 months old who were born at 35 weeks or later and are currently experiencing at least one of these digestive issues. Participation involves switching the baby to the study formula and having parents track symptoms using a standardized scale at regular clinic visits over the study period. This summary was prepared to help patients understand the study in plain language.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIETARY_SUPPLEMENTNew infant formula

The new formula will be given to infants during the 4-month study period.


Locations(4)

Site 02

Nice, France

Site 04

Paris, France

Site 03

Toulon, France

Site 01

Vincennes, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06488274


Related Trials